Company Description
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore.
The company operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices.
It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website.
The company also provides a suite of medical-related and other services, including teleconsultations and health check-up services, vaccinations, skin and aesthetics services, and other services.
In addition, it offers healthcare and wellness products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace, as well as wellness programs to corporate customers.
Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical services.
The company was founded in 2009 and is headquartered in Singapore.
| Country | Singapore |
| Founded | 2016 |
| IPO Date | Apr 10, 2024 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 88 |
| CEO | Tung Yeng Siaw |
Contact Details
Address: No. 07-06/07 Vision Exchange, 2 Venture Drive Singapore, 608526 Singapore | |
| Phone | 65 6222 5223 |
| Website | manadr.com |
Stock Details
| Ticker Symbol | MNDR |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001976695 |
| ISIN Number | KYG622641093 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Tung Yeng Siaw | Co-Chief Executive Officer and Director |
| Dr. Pui Pui Teoh | Co-Founder, Chief Operating Officer and Chairwoman of the Board |
| Aik Huat Leong | Chief Financial Officer |
| Siew Siew Chan | Chief Technology Officer |
| Dr. Seng Taat Siaw | Chief Medical Officer |
| Pei Bei Law | Chief Business Officer |
| Chien Howh Chin | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 12, 2025 | 6-K | Report of foreign issuer |
| Sep 11, 2025 | 6-K | Report of foreign issuer |
| Sep 10, 2025 | 424B5 | Filing |
| Sep 10, 2025 | 424B3 | Prospectus |
| Sep 9, 2025 | EFFECT | Notice of Effectiveness |
| Aug 26, 2025 | F-3/A | Filing |
| Aug 25, 2025 | 6-K | Report of foreign issuer |
| Aug 21, 2025 | 6-K | Report of foreign issuer |
| Aug 8, 2025 | F-3/A | Filing |
| Jul 17, 2025 | 6-K | Report of foreign issuer |